Please assess the completion status of the following clinical trial:

Trial Title: Prophylactic White Cell Transfusions Versus Therapeutic White Cell Transfusions in Patients With Leukemia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Adult and pediatric (=/\> 2 years old) patients with a diagnosis of acute myelogenous leukemia (including undifferentiated and bi-phenotypic leukemia), or high-risk myelodysplastic syndrome, or chronic myelogenous leukemia in blast crisis who will receive first or second anti-leukemia therapeutic intent with chemotherapy, targeted therapy or hypomethylating agents~2. Patients must sign an informed consent indicating they are aware of the investigational nature of this study, in keeping with the policies of the hospital.~Exclusion Criteria:~1. Patients with baseline (at start leukemia treatment) infection, defined as patients with a)fever and known positive cultures at the time of randomization; or b) chest or sinus computed tomography with findings suggestive of pneumonia or sinusitis; or c) one positive galactomannan test \>/= 1 or two positive galactomannan text \>/= 0.5 to 1~2. Patients with Zubrod performance status \>/= 3

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Arm 1 (Prophylactic Arm) (Type: EXPERIMENTAL): Prophylactic Treatment (standard of care prophylactic antibiotics) + Prophylactic White Cell Transfusion
- Arm 2 (Therapeutic Arm) (Type: EXPERIMENTAL): Prophylactic Treatment (standard of care prophylactic antibiotics) + Therapeutic White Cell Transfusion

Based on this trial design, predict the completion outcome and termination type (if applicable).